The coronavirus illness 2019 (COVID-19) pandemic, brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is threatening folks’s lives and impacting their well being. It’s nonetheless unclear whether or not folks engaged in bodily exercise are at an elevated danger of SARS-CoV-2 an infection and extreme types of COVID-19.
To be able to present knowledge to assist reply this query, we, subsequently, investigated the results of endurance coaching on the degrees of host proteins concerned in SARS-CoV-2 an infection in mice. Eight-week-old C57BL/6J mice have been subjected to treadmill operating (17-25 m/min, 60-90 min, 5 classes/week, eight weeks).
After the intervention, the degrees of angiotensin-converting enzyme 2 (ACE2; host receptor for SARS-CoV-2), transmembrane protease serine 2 (TMPRSS2; host protease priming fusion of SARS-CoV-2 to host cell membranes), FURIN (host protease that promotes binding of SARS-CoV-2 to host receptors), and Neuropilin-1 (host coreceptor for SARS-CoV-2) have been measured in 10 organs that SARS-CoV-2 can infect (larynx, trachea, lung, coronary heart, jejunum, ileum, colon, liver, kidney, and testis).
Six organs (coronary heart, lung, jejunum, liver, trachea, and ileum) confirmed modifications within the ranges of at the very least one of many proteins. Endurance coaching elevated ACE2 ranges in coronary heart (+66.4%), lung (+37.1%), jejunum (+24.7%) and liver (+27.4%), and FURIN in liver (+17.9%) tissue. In distinction, endurance coaching decreased Neuropilin-1 ranges in liver (-39.7%), trachea (-41.2%), and ileum (-39.7%), and TMPRSS2 in lung (-11.3%). Taken collectively, endurance coaching altered the degrees of host proteins concerned in SARS-CoV-2 cell entry in an organ-dependent method.

A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 An infection and Its Software in a Inhabitants-Based mostly Survey by Mail

Noninvasive salivary antibody immunoassays can allow low-cost epidemiological surveillance of infections. This research concerned creating and validating a multiplex suspension immunoassay on the Luminex platform to measure immunoglobulin G (IgG) responses to extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid and spike (S) proteins, and the spike protein’s S1 and S2 subunits and receptor binding area.
A number of variations of those recombinant proteins acquired from industrial and noncommercial sources have been evaluated. Assay growth and validation utilized saliva and serum samples from coronavirus illness 2019 (COVID-19) instances procured from industrial sources and damaging controls from a prepandemic survey.
Saliva was additionally collected in an illustration survey by mail involving grownup people in the US who have been recognized with SARS-CoV-2 an infection 15 to 80 days previous to pattern assortment. The survey had an 83% legitimate pattern return price (192 samples from 38 states).
Most COVID-19 instances (93%) reported mildly symptomatic or asymptomatic infections. The ultimate salivary assay primarily based on the best-performing spike and nucleocapsid proteins had a sensitivity of 87.1% (95% bootstrap confidence interval, 82.1 to 91.7%) and specificity of 98.5% (95.Zero to 100%) utilizing 227 and 285 saliva samples, respectively.
The identical assay had 95.9% (92.eight to 98.9%) sensitivity and 100% (98.Four to 100%) specificity in serum (174 and 285 serum samples, respectively). Salivary and serum antibody responses to spike and nucleocapsid proteins have been strongly correlated in 22 paired samples (r = 0.88 and r = 0.80, respectively). Antibody responses peaked at roughly 50 days postonset; higher sickness severity was related to stronger responses.
This research demonstrated {that a} salivary antibody assay can be utilized in large-scale inhabitants surveys by mail to raised characterize public well being impacts of COVID-19. IMPORTANCE Given the big impacts of the COVID-19 pandemic, creating instruments for inhabitants surveillance of an infection is of paramount significance.
This text describes the event of a multiplex immunoassay on a Luminex platform to measure salivary immunoglobulin G responses to the spike protein, its two subunits and receptor binding area, and the nucleocapsid protein of SARS-CoV-2. The assay validation utilized serum and saliva samples from prepandemic controls and up to date COVID-19 instances.
A survey by mail focusing on current COVID-19 instances throughout the US additionally demonstrated the utility of secure, at-home self-collection of saliva. By incorporating a number of SARS-CoV-2 proteins, this assay might differentiate responses to pure SARS-CoV-2 infections from responses to most vaccines.
Software of this noninvasive immunoassay in COVID-19 surveillance will help present estimates of cumulative incidence charges of symptomatic and asymptomatic infections in varied communities and subpopulations, temporal patterns of antibody responses, and danger components for an infection.

Roborovski hamster (Phodopus roborovskii) pressure SH101 as a systemic an infection mannequin of SARS-CoV-2

Extreme acute respiratory syndrome CoV-2 (SARS-CoV-2) is presently inflicting a worldwide menace with its unusually excessive transmission charges and fast evolution into various strains. In contrast to typical respiratory viruses, SARS-CoV-2 ceaselessly causes systemic an infection by breaking the boundaries of the respiratory methods.
The event of animal fashions recapitulating the medical manifestations of COVID-19 is of utmost significance not just for the event of vaccines and antivirals but additionally for understanding the pathogenesis. Nonetheless, there has not been developed an animal mannequin for systemic an infection of SARS-CoV-2 representing most features of the medical manifestations of COVID-19 with systemic signs.
Right here we report {that a} Roborovski hamster pressure SH101, a laboratory inbred hamster pressure of P. roborovskii, displayed most signs of systemic an infection upon SARS-CoV-2 an infection as within the case of the human counterpart, in contrast to present COVID-19 animal fashions.
Roborovski hamster pressure SH101 post-infection of SARS-CoV-2 represented most medical signs of COVID-19 resembling snuffling, labored respiratory, dyspnea, cough, hunched posture, progressive weight reduction, ruffled fur, and excessive fever following shaking chills.
Histological examinations additionally revealed preliminary right-predominated pneumonia in addition to slight organ damages within the mind and liver, manifesting systemic COVID-19 instances. Contemplating the advantage of a small animal in addition to its medical manifestations of SARS-CoV-2 an infection in human, this hamster mannequin appears to supply a perfect software to research COVID-19.

A mathematical mannequin for the dynamics of SARS-CoV-2 virus utilizing the Caputo-Fabrizio operator

The pandemic of SARS-CoV-2 virus stays a urgent problem with unpredictable traits which unfold worldwide via human interactions. The present research is specializing in the investigation and evaluation of a fractional-order epidemic mannequin that discusses the temporal dynamics of the SARS-CoV-2 virus in a group. It’s well-known that symptomatic and asymptomatic people have a significant impact on the dynamics of the SARS-CoV-2 virus subsequently, we divide the whole inhabitants into inclined, asymptomatic, symptomatic, and recovered teams of the inhabitants.
Additional, we assume that the vaccine confers everlasting immunity as a result of a number of vaccinations have commenced throughout the globe. The brand new fractional-order mannequin for the transmission dynamics of SARS-CoV-2 virus is formulated by way of the Caputo-Fabrizio fractional-order method with the upkeep of dimension in the course of the technique of fractionalization.
The speculation of mounted level will probably be used to point out that the proposed mannequin possesses a novel answer whereas the well-posedness (bounded-ness and positivity) of the fractional-order mannequin options are mentioned.

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-100ug
QP13422-100ug 100ug
EUR 261.6

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-1mg
QP13422-1mg 1mg
EUR 1273.2

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-500ug
QP13422-500ug 500ug
EUR 795.6

Recombinant SARS Associated Spike Mosaic S(N)
7-07093 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S(N)
7-07094 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S(N)
7-07095 1000µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07096 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07097 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)
7-07098 1000µg Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07099 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07100 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S©
7-07101 1000µg Ask for price

SARS Coronavirus Spike Mosaic Recombinant protein (Center)
39-122 0.1 mg
EUR 556.8
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

SARS Associated Spike Mosaic S(M) Protein
20-abx260155
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

SARS Associated Spike Mosaic S(N) Protein
20-abx260157
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1422 100 ug
EUR 343.2

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1423 100 ug
EUR 343.2

Recombinant (E.Coli) SARS Associated Spike Mosaic S
RP-1424 100 ug
EUR 343.2

SARS Coronavirus Spike Mosaic Recombinant protein (C-terminus)
39-123 0.1 mg
EUR 556.8
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

SARS Coronavirus Spike Mosaic Recombinant protein (N-terminus)
39-124 0.1 mg
EUR 556.8
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

Recombinant SARS Spike Mosaic Protein S (N-Terminal)
VAng-Lsx0073-inquire inquire Ask for price
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli.

SARS-CoV-2 (COVID-19) Nucleocapsid Mosaic Recombinant protein
39-115 0.05 mg
EUR 556.8
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

SARS-CoV-2 (COVID-19) Spike E Mosaic Recombinant protein
39-114 0.05 mg
EUR 556.8
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573)
VAng-Lsx0056-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203)
VAng-Lsx0055-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190)
VAng-Lsx0057-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Cytomegalo Virus Mosaic
PR27123 500 ug
EUR 999.6

Sars/ Rat Sars ELISA Kit
ELI-41050r 96 Tests
EUR 1063.2

SARS Antibody
1-CSB-PA020709GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against SARS. Recognizes SARS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

SARS Antibody
1-CSB-PA04145A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

SARS Antibody
DF15539 100ul
EUR 420

SARS siRNA
20-abx932473
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

SARS siRNA
20-abx932474
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

SARS antibody
70R-20086 50 ul
EUR 522
Description: Rabbit polyclonal SARS antibody

SARS antibody
70R-1444 100 ug
EUR 452.4
Description: Rabbit polyclonal SARS antibody raised against the C terminal of SARS

SARS antibody
70R-1445 100 ug
EUR 452.4
Description: Rabbit polyclonal SARS antibody raised against the middle region of SARS

SARS antibody
39139-100ul 100ul
EUR 302.4

SARS siRNA
20-abx904776
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

pENTR223-SARS
PVT12269 2 ug
EUR 469.2

HTLV Mosaic protein [GST]
DAG1572 100 µg
EUR 774

EBV P18 Mosaic protein
DAG1582 100 µg
EUR 774

Turnip mosaic virus Polyprotein
1-CSB-EP2708TJM
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Turnip mosaic virus Polyprotein,partial expressed in E.coli

Recombinant Malaria Cs Mosaic
7-07090 100µg Ask for price

Recombinant Malaria Cs Mosaic
7-07091 500µg Ask for price

Recombinant Malaria Cs Mosaic
7-07092 1000µg Ask for price

Recombinant Cytomegalo Virus Mosaic
7-07525 100µg Ask for price

Recombinant Cytomegalo Virus Mosaic
7-07526 500µg Ask for price

Recombinant Cytomegalo Virus Mosaic
7-07527 1000µg Ask for price

Recombinant HTLV-1 Mosaic
7-07771 100µg Ask for price

Recombinant HTLV-1 Mosaic
7-07772 500µg Ask for price

Recombinant HTLV-1 Mosaic
7-07773 1000µg Ask for price

HTLV-1 Mosaic Protein
20-abx260286
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Malaria Cs Mosaic Protein
20-abx260295
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Rubella Virus E1 Mosaic
PR27125 500 ug
EUR 999.6

Recombinant HEV Mosaic Protein
VAng-Lsx0225-inquire inquire Ask for price
Description: HEV Mosaic Protein, recombinant protein from E. coli.

HTLV Glycoprotein 46 Mosaic protein
DAG1571 100 µg
EUR 774

EBV Mosaic EBNA1 protein [GST]
DAG1577 100 µg
EUR 774

Arthrobacter globiformis Mosaic Protein [His]
DAG1731 100 ug
EUR 1098

Cucumber mosaic virus Helicase (ORF1a)
1-CSB-CF2240CMV
  • EUR 1158.00
  • EUR 798.00
  • EUR 858.00
  • 1MG
  • 200ug
  • 500ug
Description: Recombinant Cucumber mosaic virus Helicase(ORF1a) expressed in in vitro E.coli expression system

Recombinant Treponema pallidum p41 Mosaic
7-07570 100µg Ask for price

Recombinant Treponema pallidum p41 Mosaic
7-07571 500µg Ask for price

Recombinant Treponema pallidum p41 Mosaic
7-07572 1000µg Ask for price

Recombinant Rubella Virus E1 Mosaic
7-07858 100µg Ask for price

Recombinant Rubella Virus E1 Mosaic
7-07859 500µg Ask for price

Recombinant Rubella Virus E1 Mosaic
7-07860 1000µg Ask for price

HCV NS4 mosaic recombinant antigen
00155-V-01mg 0,1 mg
EUR 321
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5.

HCV NS4 mosaic recombinant antigen
00155-V-1000ug 1000 ug
EUR 1539
Description: HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5.

Cucumber Mosaic Virus ELISA Kit
abx157282-96tests 96 tests
EUR 801.6

Rubella Virus E1 Mosaic Protein
abx060646-1mg 1 mg
EUR 2214

Rubella Virus E1 Mosaic Protein
abx060647-1mg 1 mg
EUR 1796.4

Treponema pallidum p41 Mosaic Protein
20-abx260173
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Rubella Virus E1 Mosaic Protein
20-abx260310
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant EBV P18 Mosaic Protein
VAng-Lsx0115-inquire inquire Ask for price
Description: EBV P18 Mosaic protein, recombinant protein from E. coli.

Recombinant HEV Mosaic-S Protein
VAng-Lsx0226-inquire inquire Ask for price
Description: HEV Mosaic-S Protein, recombinant protein from E. coli.

Recombinant HTLV Mosaic Protein [GST]
VAng-Lsx0304-inquire inquire Ask for price
Description: Recombinant HTLV protein fused with GST at N-terminus was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant HTLV-1 Mosaic Protein
VAng-Lsx0310-inquire inquire Ask for price
Description: HTLV type 1 Mosaic Protein, recombinant protein from E. coli.

Recombinant MeV Hemagglutinin Mosaic Protein
VAng-Lsx0386-inquire inquire Ask for price
Description: Recombinant MeV HA protein containing the large hemagglutinin immunodominant regions 1-30, 115-150 and 379-410 amino acids was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant MeV Fusion Mosaic Protein
VAng-Lsx0387-inquire inquire Ask for price
Description: MeV Fusion Mosaic protein, recombinant protein from E. coli.

Recombinant RuV E1 Mosaic Protein
VAng-Lsx0488-100g 100 µg
EUR 1155.6
Description: RuV E1 Mosaic, recombinant protein from E. coli.

Recombinant RuV E1 Mosaic Protein
VAng-Lsx0488-1mg 1 mg
EUR 2587.2
Description: RuV E1 Mosaic, recombinant protein from E. coli.

Recombinant RuV E1 Mosaic Protein
VAng-Lsx0488-500g 500 µg
EUR 1892.4
Description: RuV E1 Mosaic, recombinant protein from E. coli.

Recombinant SARS SARS Core Protein, Untagged, E.coli-100ug
QP10499-100ug 100ug
EUR 261.6

Recombinant SARS SARS Core Protein, Untagged, E.coli-1mg
QP10499-1mg 1mg
EUR 1273.2

Recombinant SARS SARS Core Protein, Untagged, E.coli-500ug
QP10499-500ug 500ug
EUR 795.6

Recombinant SARS SARS Core Protein, Untagged, E.coli-100ug
QP13416-100ug 100ug
EUR 261.6

Recombinant SARS SARS Core Protein, Untagged, E.coli-1mg
QP13416-1mg 1mg
EUR 1273.2

Recombinant SARS SARS Core Protein, Untagged, E.coli-500ug
QP13416-500ug 500ug
EUR 795.6

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-100ug
QP13417-100ug 100ug
EUR 261.6

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-1mg
QP13417-1mg 1mg
EUR 1273.2

Recombinant SARS SARS Envelope Protein, Untagged, E.coli-500ug
QP13417-500ug 500ug
EUR 795.6

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-100ug
QP13418-100ug 100ug
EUR 261.6

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-1mg
QP13418-1mg 1mg
EUR 1273.2

Recombinant SARS SARS Matrix Protein, Untagged, E.coli-500ug
QP13418-500ug 500ug
EUR 795.6

Recombinant SARS SARS MERS Protein, His, E.coli-100ug
QP13419-100ug 100ug
EUR 261.6

Recombinant SARS SARS MERS Protein, His, E.coli-1mg
QP13419-1mg 1mg
EUR 1513.2

Recombinant SARS SARS MERS Protein, His, E.coli-500ug
QP13419-500ug 500ug
EUR 795.6

Recombinant SARS SARS-CoV Protein, His, E.coli-1mg
QP13423-1mg 1mg
EUR 4744.8

Recombinant SARS SARS-CoV Protein, His, E.coli-20ug
QP13423-20ug 20ug
EUR 241.2

Recombinant SARS SARS-CoV Protein, His, E.coli-5ug
QP13423-5ug 5ug
EUR 186

SARS S1 [His]
DAG1861 500 ug
EUR 3034.8

SARS S2 [His]
DAG1862 500 ug
EUR 3034.8

SARS Conjugated Antibody
C39139 100ul
EUR 476.4

SARS cloning plasmid
CSB-CL020709HU1-10ug 10ug
EUR 451.2
Description: A cloning plasmid for the SARS gene.

SARS cloning plasmid
CSB-CL020709HU2-10ug 10ug
EUR 451.2
Description: A cloning plasmid for the SARS gene.

anti- SARS antibody
FNab07609 100µg
EUR 658.5
Description: Antibody raised against SARS

SARS Spike Peptide
3219P 0.05 mg
EUR 197.7
Description: (NT) SARS Spike peptide

SARS Rabbit pAb
A13350-100ul 100 ul
EUR 369.6

SARS Rabbit pAb
A13350-200ul 200 ul
EUR 550.8

SARS Rabbit pAb
A13350-20ul 20 ul
EUR 219.6

SARS Rabbit pAb
A13350-50ul 50 ul
EUR 267.6

SARS Spike Antibody
24216-100ul 100ul
EUR 468

SARS Spike Antibody
24217-100ul 100ul
EUR 468

SARS Spike Antibody
24218-100ul 100ul
EUR 468

SARS Spike Antibody
24219-100ul 100ul
EUR 468

SARS Spike Antibody
24318-100ul 100ul
EUR 468

SARS Matrix Antibody
24319-100ul 100ul
EUR 468

SARS Matrix Antibody
24320-100ul 100ul
EUR 468

SARS Envelope Antibody
24321-100ul 100ul
EUR 468

SARS Envelope Antibody
24322-100ul 100ul
EUR 468

SARS Blocking Peptide
33R-7048 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARS antibody, catalog no. 70R-1444

SARS Spike Peptide
3525P 0.05 mg
EUR 197.7
Description: (CT) SARS Spike peptide

SARS Matrix Peptide
3527P 0.05 mg
EUR 197.7
Description: (NT) SARS Matrix peptide

SARS Matrix Peptide
3529P 0.05 mg
EUR 197.7
Description: (CT) SARS Matrix peptide

SARS Envelope Peptide
3531P 0.05 mg
EUR 197.7
Description: (NT) SARS Envelope peptide

SARS Envelope Peptide
3533P 0.05 mg
EUR 197.7
Description: (CT) SARS Envelope peptide

SARS Blocking Peptide
33R-8713 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARS antibody, catalog no. 70R-1445

SARS Coronavirus antibody
10C-CR9003M1 100 ug
EUR 598.8
Description: Mouse monoclonal SARS Coronavirus antibody

SARS Nucleocapsid antibody
10R-10470 100 ug
EUR 522
Description: Mouse monoclonal SARS Nucleocapsid antibody

SARS Nucleocapsid antibody
10R-10471 100 ug
EUR 522
Description: Mouse monoclonal SARS Nucleocapsid antibody

SARS E2 antibody
10R-1976 100 ul
EUR 289.2
Description: Mouse monoclonal SARS E2 antibody

SARS M antibody
10R-1977 100 ul
EUR 289.2
Description: Mouse monoclonal SARS M antibody

SARS Spike Antibody
20-abx137184
  • EUR 1262.40
  • EUR 1846.80
  • EUR 2064.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Nucleocapsid Antibody
20-abx137185
  • EUR 1262.40
  • EUR 1846.80
  • EUR 2364.00
  • 100 ug
  • 200 ug
  • 300 µg

SARS Spike Antibody
20-abx137200
  • EUR 1412.40
  • EUR 2264.40
  • EUR 2665.20
  • 100 ug
  • 200 ug
  • 300 µg

SARS Nucleocapsid Antibody
20-abx137201
  • EUR 1412.40
  • EUR 2264.40
  • EUR 2665.20
  • 100 ug
  • 200 ug
  • 300 µg

SARS-E2 Antibody
abx016055-100ul 100 ul
EUR 493.2

SARS-M Antibody
abx016056-100ul 100 ul
EUR 493.2

SARS Rabbit pAb
A6733-100ul 100 ul
EUR 369.6

SARS Rabbit pAb
A6733-200ul 200 ul
EUR 550.8

SARS Rabbit pAb
A6733-20ul 20 ul
EUR 219.6

SARS Rabbit pAb
A6733-50ul 50 ul
EUR 267.6

SARS Protease Substrate
H-5982.0500 0.5mg
EUR 356.4
Description: Sum Formula: C66H119N21O22S; CAS# [587886-51-9] net

SARS Protease Substrate
H-5982.1000 1.0mg
EUR 618
Description: Sum Formula: C66H119N21O22S; CAS# [587886-51-9] net

Anti-SARS antibody
PAab07609 100 ug
EUR 463.2

Anti-SARS antibody
STJ28816 100 µl
EUR 332.4
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown.

Anti-SARS antibody
STJ115313 100 µl
EUR 332.4
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown.

SARS Polyclonal Antibody
A71293-050 50 ul
EUR 302.5

SARS Polyclonal Antibody
A71293-100 100 ul
EUR 423.5

Anti-SARS (1H4)
YF-MA10816 100 ug
EUR 435.6
Description: Mouse monoclonal to SARS

SARS Polyclonal Antibody
A53977-020 20 ul
EUR 117.7

SARS Polyclonal Antibody
A53977-050 50 ul
EUR 302.5

SARS Polyclonal Antibody
A53977-100 100 ul
EUR 423.5

SARS Polyclonal Antibody
A53977
  • EUR 684.66
  • EUR 117.70
  • EUR 302.50
  • EUR 423.50
  • 100 µg
  • 20 ul
  • 50 ul
  • 100 ul

SARS Polyclonal Antibody
A71293
  • EUR 302.50
  • EUR 423.50
  • 50 ul
  • 100 ul

Recombinant (E.Coli) Circumsporozoite (CSP) mosaic protein (107-129, 334-351 aa) (P.falciparum) mosaic protein
CSPF16-R 50 ug
EUR 416.4

Recombinant P. Falciparum Circumsporozoite Mosaic protein
DAG1344 100 µg
EUR 774

Recombinant Herpes Simplex Virus-8 Mosaic
7-07138 100µg Ask for price

Recombinant Herpes Simplex Virus-8 Mosaic
7-07139 500µg Ask for price

Recombinant Herpes Simplex Virus-8 Mosaic
7-07140 1000µg Ask for price

Recombinant Hepatitis C Virus NS4 Mosaic 
7-07300 100µg Ask for price

Recombinant Hepatitis C Virus NS4 Mosaic 
7-07301 500µg Ask for price

Recombinant Hepatitis C Virus NS4 Mosaic 
7-07302 500µg Ask for price

Recombinant HIV-1 gp120 nef Mosaic
7-07657 100µg Ask for price

Recombinant HIV-1 gp120 nef Mosaic
7-07658 500µg Ask for price

Recombinant HIV-1 gp120 nef Mosaic
7-07659 1000µg Ask for price

HTLV-1 virus mosaic recombinant antigen
00205-V-01mg 0,1 mg
EUR 321
Description: HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207.

HTLV-1 virus mosaic recombinant antigen
00205-V-1000ug 1000 ug
EUR 1539
Description: HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207.

HHV-4 recombinant mosaic EBNA1 antigen
00212-V-01mg 0,1 mg
EUR 321
Description: HHV-4 recombinant mosaic EBNA1 antigen. Region: 1-90/408-498aa

HHV-4 recombinant mosaic EBNA1 antigen
00212-V-1000ug 1000 ug
EUR 1539
Description: HHV-4 recombinant mosaic EBNA1 antigen. Region: 1-90/408-498aa

Rubella virus E1 mosaic recombinant antigen
00215-V-01mg 0,1 mg
EUR 321
Description: Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.

Rubella virus E1 mosaic recombinant antigen
00215-V-1000ug 1000 ug
EUR 1539
Description: Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.

Hepatitis C Virus NS4 Mosaic Protein
20-abx260127
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

HIV-1 gp120 nef Mosaic Protein
20-abx260272
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Herpes Simplex Virus-8 Mosaic Protein
20-abx260329
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant HEV Mosaic ORF2, ORF3 Protein
VAng-Lsx0223-inquire inquire Ask for price
Description: HEV Mosaic ORF2, ORF3, recombinant protein from E. coli.

Recombinant (E.Coli) Treponema pallidum p41 Mosaic
RP-1445 100 ug
EUR 343.2

Recombinant HTLV gp 46 Mosaic Protein
VAng-Lsx0303-inquire inquire Ask for price
Description: Recombinant HTLV gp46 protein containing the gp46 immunodominant regions, 162-214 amino acids and 242-257 amino acids was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant RuV E1 Mosaic Protein [His]
VAng-Lsx0489-inquire inquire Ask for price
Description: RuV E1 Mosaic [His], recombinant protein from E. coli.

SARS Antibody, HRP conjugated
1-CSB-PA04145B0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

SARS Antibody, FITC conjugated
1-CSB-PA04145C0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is FITC conjugated. Tested in the following application: ELISA

SARS Antibody, Biotin conjugated
1-CSB-PA04145D0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against SARS. Recognizes SARS from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA

Human SARS shRNA Plasmid
20-abx954245
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse SARS shRNA Plasmid
20-abx972567
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Rat SARS shRNA Plasmid
20-abx988123
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

SARS-CoV Spike Antibody
3219-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3219-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3221-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS (IN1) Spike Peptide
3221P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN1) Spike peptide

SARS-CoV Spike Antibody
3223-002mg 0.02 mg
EUR 206.18
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3223-01mg 0.1 mg
EUR 523.7
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS (IN2) Spike Peptide
3223P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN2) Spike peptide

SARS-CoV Spike Antibody
3225-002mg 0.02 mg
EUR 206.18
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS-CoV Spike Antibody
3225-01mg 0.1 mg
EUR 523.7
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

SARS (IN3) Spike Peptide
3225P 0.05 mg
EUR 197.7
Description: (IN) SARS (IN3) Spike peptide

SARS-CoV Matrix Antibody
3527-002mg 0.02 mg
EUR 206.18
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).

SARS-CoV Matrix Antibody
3527-01mg 0.1 mg
EUR 523.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3). It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4).
The regular states of the mannequin are analyzed and the sensitivity evaluation of the fundamental reproductive quantity is explored. Furthermore to parameterize the mannequin an actual knowledge of SARS-CoV-2 virus reported within the Sultanate of Oman from January 1st, 2021 to Could 23rd, 2021 are used. We then carry out the massive scale numerical findings to point out the validity of the analytical work.

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here